retatrutide clinical trials review safety profile A of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity VisualAbstract: Retatrutide reduces body weight
Pay in 4 interest-free payments of $6.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4



























